Abstract
It is well accepted that the ability of a biologically molecule to selectively find its target influences its potential as a successful therapeutic drug. For many molecules the molecular target is located inside sub-cellular structures. Molecules with such sub cellular targets and the inability to specifically accumulate at the location of the target can potentially be made more active by targeting strategies that improve their accumulation at the target. Pharmaceutical nanocarriers form the basis of several such targeting strategies. This chapter deals with the rational approach underlying the current uses of nanocarriers to deliver bioactive molecules to sub cellular compartments.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Akita, H., et al., Multi-layered nanoparticles for penetrating the endosome and nuclear membrane via a step-wise membrane fusion process. Biomaterials, 2009. 30(15): p. 2940–9.
Allen, T.D., et al., The nuclear pore complex: mediator of translocation between nucleus and cytoplasm. J Cell Sci, 2000. 113 (Pt 10): p. 1651–9.
Bae, Y., et al., Preparation and biological characterization of polymeric micelle drug carriers with intracellular pH-triggered drug release property: tumor permeability, controlled subcellular drug distribution, and enhanced in vivo antitumor efficacy. Bioconjug Chem, 2005. 16(1): p. 122–30.
Bareford, L.M. and P.W. Swaan, Endocytic mechanisms for targeted drug delivery. Adv Drug Deliv Rev, 2007. 59(8): p. 748–58.
Boddapati, S.V., et al., Mitochondriotropic liposomes. J Liposome Res, 2005. 15(1–2): p. 49–58.
Boddapati, S.V., et al., Organelle-targeted nanocarriers: specific delivery of liposomal ceramide to mitochondria enhances its cytotoxicity in vitro and in vivo. Nano Lett, 2008. 8(8): p. 2559–63.
Boussif, O., et al., A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci U S A, 1995. 92(16): p. 7297–301.
Breunig, M., S. Bauer, and A. Goepferich, Polymers and nanoparticles: intelligent tools for intracellular targeting? Eur J Pharm Biopharm, 2008. 68(1): p. 112–28.
Calzolari, A., et al., Transferrin receptor 2 is frequently expressed in human cancer cell lines. Blood Cells Mol Dis, 2007. 39(1): p. 82–91.
Castino, R., M. Demoz, and C. Isidoro, Destination ‘lysosome’: a target organelle for tumour cell killing? J Mol Recognit, 2003. 16(5): p. 337–48.
Cervetti, G., et al., Efficacy and toxicity of liposomal daunorubicin included in PVABEC regimen for aggressive NHL of the elderly. Leuk Lymphoma, 2003. 44(3): p. 465–9.
Costin, G.E., et al., pH-sensitive liposomes are efficient carriers for endoplasmic reticulum-targeted drugs in mouse melanoma cells. Biochem Biophys Res Commun, 2002. 293(3): p. 918–23.
Demeneix, B. and J.P. Behr, Polyethylenimine (PEI). Adv Genet, 2005. 53: p. 217–30.
D’Souza, G.G., et al., DQAsome-mediated delivery of plasmid DNA toward mitochondria in living cells. J Control Release, 2003. 92(1–2): p. 189–97.
D’Souza, G.G., S.V. Boddapati, and V. Weissig, Mitochondrial leader sequence--plasmid DNA conjugates delivered into mammalian cells by DQAsomes co-localize with mitochondria. Mitochondrion, 2005. 5(5): p. 352–8.
D’Souza, G.G., et al., Nanocarrier-assisted sub-cellular targeting to the site of mitochondria improves the pro-apoptotic activity of paclitaxel. J Drug Target, 2008. 16(7): p. 578–85.
Dufes, C., et al., Anticancer drug delivery with transferrin targeted polymeric chitosan vesicles. Pharm Res, 2004. 21(1): p. 101–7.
Duvvuri, M. and J.P. Krise, Intracellular drug sequestration events associated with the emergence of multidrug resistance: a mechanistic review. Front Biosci, 2005. 10: p. 1499–509.
Dzau, V.J., et al., Fusigenic viral liposome for gene therapy in cardiovascular diseases. Proc Natl Acad Sci U S A, 1996. 93(21): p. 11421–5.
Eavarone, D.A., X. Yu, and R.V. Bellamkonda, Targeted drug delivery to C6 glioma by transferrin-coupled liposomes. J Biomed Mater Res, 2000. 51(1): p. 10–4.
Ellis, R.J. and A.P. Minton, Cell biology: join the crowd. Nature, 2003. 425(6953): p. 27–8.
Ellouze, S., et al., Optimized allotopic expression of the human mitochondrial ND4 prevents blindness in a rat model of mitochondrial dysfunction. Am J Hum Genet, 2008. 83(3): p. 373–87.
Fang, J., T. Sawa, and H. Maeda, Factors and mechanism of “EPR” effect and the enhanced antitumor effects of macromolecular drugs including SMANCS. Adv Exp Med Biol, 2003. 519: p. 29–49.
Fawell, S., et al., Tat-mediated delivery of heterologous proteins into cells. Proc Natl Acad Sci U S A, 1994. 91(2): p. 664–8.
Fernandez-Carneado, J., et al., Highly efficient, nonpeptidic oligoguanidinium vectors that selectively internalize into mitochondria. J Am Chem Soc, 2005. 127(3): p. 869–74.
Fittipaldi, A. and M. Giacca, Transcellular protein transduction using the Tat protein of HIV-1. Adv Drug Deliv Rev, 2005. 57(4): p. 597–608.
Gabizon, A., et al., Systemic administration of doxorubicin-containing liposomes in cancer patients: a phase I study. Eur J Cancer Clin Oncol, 1989. 25(12): p. 1795–803.
Gabizon, A., R. Shiota, and D. Papahadjopoulos, Pharmacokinetics and tissue distribution of doxorubicin encapsulated in stable liposomes with long circulation times. J Natl Cancer Inst, 1989. 81(19): p. 1484–8.
Gill, P.S., et al., Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Kaposi’s sarcoma. J Clin Oncol, 1996. 14(8): p. 2353–64.
Glickson, J.D., et al., Lipoprotein nanoplatform for targeted delivery of diagnostic and therapeutic agents. Mol Imaging, 2008. 7(2): p. 101–10.
Glickson, J.D., et al., Lipoprotein nanoplatform for targeted delivery of diagnostic and therapeutic agents. Adv Exp Med Biol, 2009. 645: p. 227–39.
Goins, A.B., H. Sanabria, and M.N. Waxham, Macromolecular crowding and size effects on probe microviscosity. Biophys J, 2008. 95(11): p. 5362–73.
Gray, R.E., et al., Allotopic expression of mitochondrial ATP synthase genes in nucleus of Saccharomyces cerevisiae. Methods Enzymol, 1996. 264: p. 369–89.
Gregoriadis, G. and B.E. Ryman, Liposomes as carriers of enzymes or drugs: a new approach to the treatment of storage diseases. Biochem J, 1971. 124(5): p. 58P.
Greish, K., Enhanced permeability and retention (EPR) effect for anticancer nanomedicine drug targeting. Methods Mol Biol, 2010. 624: p. 25–37.
Hansen, J.S., et al., Acyl-CoA-binding protein (ACBP) localizes to the endoplasmic reticulum and Golgi in a ligand-dependent manner in mammalian cells. Biochem J, 2008. 410(3): p. 463–72.
Horobin, R.W., S. Trapp, and V. Weissig, Mitochondriotropics: a review of their mode of action, and their applications for drug and DNA delivery to mammalian mitochondria. J Control Release, 2007. 121(3): p. 125–36.
Hoshino, A., et al., Quantum dots targeted to the assigned organelle in living cells. Microbiol Immunol, 2004. 48(12): p. 985–94.
Inoki, Y., et al., Proteoliposomes colocalized with endogenous mitochondria in mouse fertilized egg. Biochem Biophys Res Commun, 2000. 278(1): p. 183–91.
Ju-Nam, Y., et al., Phosphonioalkylthiosulfate zwitterions--new masked thiol ligands for the formation of cationic functionalised gold nanoparticles. Org Biomol Chem, 2006. 4(23): p. 4345–51.
Kaufmann, A.M. and J.P. Krise, Lysosomal sequestration of amine-containing drugs: analysis and therapeutic implications. J Pharm Sci, 2007. 96(4): p. 729–46.
Kievit, F.M., et al., Chlorotoxin labeled magnetic nanovectors for targeted gene delivery to glioma. ACS Nano, 2010. 4(8): p. 4587–94.
Le, P.U. and I.R. Nabi, Distinct caveolae-mediated endocytic pathways target the Golgi apparatus and the endoplasmic reticulum. J Cell Sci, 2003. 116(Pt 6): p. 1059–71.
Lee, M., et al., DNA delivery to the mitochondria sites using mitochondrial leader peptide conjugated polyethylenimine. J Drug Target, 2007. 15(2): p. 115–22.
Li, S.D. and L. Huang, Pharmacokinetics and biodistribution of nanoparticles. Mol Pharm, 2008. 5(4): p. 496–504.
Liberman, E.A., et al., Mechanism of coupling of oxidative phosphorylation and the membrane potential of mitochondria. Nature, 1969. 222(5198): p. 1076–8.
Maeda, H., et al., Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Release, 2000. 65(1–2): p. 271–84.
Martin, M.E. and K.G. Rice, Peptide-guided gene delivery. AAPS J, 2007. 9(1): p. E18–29.
Maysinger, D., et al., Fate of micelles and quantum dots in cells. Eur J Pharm Biopharm, 2007. 65(3): p. 270–81.
Minton, A.P., How can biochemical reactions within cells differ from those in test tubes? J Cell Sci, 2006. 119(Pt 14): p. 2863–9.
Muro, S., E.H. Schuchman, and V.R. Muzykantov, Lysosomal enzyme delivery by ICAM-1-targeted nanocarriers bypassing glycosylation- and clathrin-dependent endocytosis. Mol Ther, 2006. 13(1): p. 135–41.
Muro, S., et al., Control of endothelial targeting and intracellular delivery of therapeutic enzymes by modulating the size and shape of ICAM-1-targeted carriers. Mol Ther, 2008. 16(8): p. 1450–8.
Murphy, M.P., Targeting lipophilic cations to mitochondria. Biochim Biophys Acta, 2008. 1777(7–8): p. 1028–31.
Murphy, M.P. and R.A. Smith, Targeting antioxidants to mitochondria by conjugation to lipophilic cations. Annu Rev Pharmacol Toxicol, 2007. 47: p. 629–56.
Northfelt, D.W., et al., Doxorubicin encapsulated in liposomes containing surface-bound polyethylene glycol: pharmacokinetics, tumor localization, and safety in patients with AIDS-related Kaposi’s sarcoma. J Clin Pharmacol, 1996. 36(1): p. 55–63.
Oca-Cossio, J., et al., Limitations of allotopic expression of mitochondrial genes in mammalian cells. Genetics, 2003. 165(2): p. 707–20.
Panyam, J. and V. Labhasetwar, Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev, 2003. 55(3): p. 329–47.
Patil, Y. and J. Panyam, Polymeric nanoparticles for siRNA delivery and gene silencing. Int J Pharm, 2009. 367(1–2): p. 195–203.
Pollock, S., et al., Uptake and trafficking of liposomes to the endoplasmic reticulum. FASEB J, 2010. 24(6): p. 1866–78.
Qian, Z.M., et al., Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway. Pharmacol Rev, 2002. 54(4): p. 561–87.
Rajendran, L., et al., Subcellular targeting strategies for drug design and delivery. Nat Rev Drug Discovery, 2010. 9(1): p. 29–42.
Ross, M.F., et al., Rapid and extensive uptake and activation of hydrophobic triphenylphosphonium cations within cells. Biochem J, 2008. 411(3): p. 633–45.
Rousselle, C., et al., New advances in the transport of doxorubicin through the blood-brain barrier by a peptide vector-mediated strategy. Mol Pharmacol, 2000. 57(4): p. 679–86.
Ruan, G., et al., Imaging and tracking of tat peptide-conjugated quantum dots in living cells: new insights into nanoparticle uptake, intracellular transport, and vesicle shedding. J Am Chem Soc, 2007. 129(47): p. 14759–66.
Savic, R., et al., Micellar nanocontainers distribute to defined cytoplasmic organelles. Science, 2003. 300(5619): p. 615–8.
Savic, R., et al., Assessment of the integrity of poly(caprolactone)-b-poly(ethylene oxide) micelles under biological conditions: a fluorogenic-based approach. Langmuir, 2006. 22(8): p. 3570–8.
Savic, R., et al., Block-copolymer micelles as carriers of cell signaling modulators for the inhibition of JNK in human islets of Langerhans. Biomaterials, 2009.
Schwarze, S.R., et al., In vivo protein transduction: delivery of a biologically active protein into the mouse. Science, 1999. 285(5433): p. 1569–72.
Seibel, P., et al., Transfection of mitochondria: strategy towards a gene therapy of mitochondrial DNA diseases. Nucleic Acids Res, 1995. 23(1): p. 10–7.
Seksek, O., J. Biwersi, and A.S. Verkman, Translational diffusion of macromolecule-sized solutes in cytoplasm and nucleus. J Cell Biol, 1997. 138(1): p. 131–42.
Sharma, A., U.S. Sharma, and R.M. Straubinger, Paclitaxel-liposomes for intracavitary therapy of intraperitoneal P388 leukemia. Cancer Lett, 1996. 107(2): p. 265–72.
Sharma, A., et al., Activity of paclitaxel liposome formulations against human ovarian tumor xenografts. Int J Cancer, 1997. 71(1): p. 103–7.
Shiraishi, T. and P.E. Nielsen, Enhanced delivery of cell-penetrating peptide-peptide nucleic acid conjugates by endosomal disruption. Nat Protoc, 2006. 1(2): p. 633–6.
Smith, R.A., et al., Delivery of bioactive molecules to mitochondria in vivo. Proc Natl Acad Sci U S A, 2003. 100(9): p. 5407–12.
Song, W.J., et al., Gold nanoparticles capped with polyethyleneimine for enhanced siRNA delivery. Small, 2010. 6(2): 239–46.
Stathopoulos, G.P.,Liposomal Cisplatin: a new cisplatin formulation. Anticancer Drugs, 2010. 21(8): p. 732–6.
Stoffler, D., B. Fahrenkrog, and U. Aebi, The nuclear pore complex: from molecular architecture to functional dynamics. Curr Opin Cell Biol, 1999. 11(3): p. 391–401.
Stoorvogel, W., H.J. Geuze, and G.J. Strous, Sorting of endocytosed transferrin and asialoglycoprotein occurs immediately after internalization in HepG2 cells. J Cell Biol, 1987. 104(5): p. 1261–8.
Suh, J., et al., PEGylation of nanoparticles improves their cytoplasmic transport. Int J Nanomedicine, 2007. 2(4): p. 735–41.
Tahara, K., et al., Chitosan-modified poly(D,L-lactide-co-glycolide) nanospheres for improving siRNA delivery and gene-silencing effects. Eur J Pharm Biopharm, 2010. 74(3): p. 421–6.
Tarrago-Trani, M.T. and B. Storrie, Alternate routes for drug delivery to the cell interior: pathways to the Golgi apparatus and endoplasmic reticulum. Adv Drug Deliv Rev, 2007. 59(8): p. 782–97.
Tate, B.A. and P.M. Mathews, Targeting the role of the endosome in the pathophysiology of Alzheimer’s disease: a strategy for treatment. Sci Aging Knowledge Environ, 2006. 2006(10): p. re2.
Tkachenko, A.G., et al., Cellular trajectories of peptide-modified gold particle complexes: comparison of nuclear localization signals and peptide transduction domains. Bioconjug Chem, 2004. 15(3): p. 482–90.
Torchilin, V.P., Recent approaches to intracellular delivery of drugs and DNA and organelle targeting. Annu Rev Biomed Eng, 2006. 8: p. 343–75.
Torchilin, V.P., et al., TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors. Proc Natl Acad Sci U S A, 2001. 98(15): p. 8786–91.
Torchilin, V.P., Nanotechnology for Intracellular Delivery and Targeting, in Nanotechnology in Drug Delivery, M.M. de Villiers, G.S. Kwon, and P. Aramwit, Editors. 2009, Springer Publications: New York. p. 313–348.
Trinder, D. and E. Baker, Transferrin receptor 2: a new molecule in iron metabolism. Int J Biochem Cell Biol, 2003. 35(3): p. 292–6.
Vaidya, B.P., R., Rai, S., Khatri, K., Goyal, A.K., Mishra, N., Vyas, S.P., Cell-selective mitochondrial targeting: A new approach for cancer therapy. Cancer Therapy, 2009. 7: p. 141–148.
Vale, R.D., Intracellular transport using microtubule-based motors. Annu Rev Cell Biol, 1987. 3: p. 347–78.
Walter, P., et al., The protein translocation machinery of the endoplasmic reticulum. Philos Trans R Soc Lond B Biol Sci, 1982. 300(1099): p. 225–8.
Weissig, V., Mitochondrial-targeted drug and DNA delivery. Crit Rev Ther Drug Carrier Syst, 2003. 20(1): p. 1–62.
Weissig, V., Targeted drug delivery to mammalian mitochondria in living cells. Expert Opin Drug Deliv, 2005. 2(1): p. 89–102.
Weissig, V. and V.P. Torchilin, Mitochondriotropic cationic vesicles: a strategy towards mitochondrial gene therapy. Curr Pharm Biotechnol, 2000. 1(4): p. 325–46.
Weissig, V. and V.P. Torchilin, Towards mitochondrial gene therapy: DQAsomes as a strategy. J Drug Target, 2001. 9(1): p. 1–13.
Weissig, V. and V.P. Torchilin, Cationic bolasomes with delocalized charge centers as mitochondria-specific DNA delivery systems. Adv Drug Deliv Rev, 2001. 49(1–2): p. 127–49.
Weissig, V., C. Lizano, and V.P. Torchilin, Selective DNA release from DQAsome/DNA complexes at mitochondria-like membranes. Drug Deliv, 2000. 7(1): p. 1–5.
Weissig, V., G.G. D’Souza, and V.P. Torchilin, DQAsome/DNA complexes release DNA upon contact with isolated mouse liver mitochondria. J Control Release, 2001. 75(3): p. 401–8.
Weissig, V., S.M. Cheng, and G.G. D’Souza, Mitochondrial pharmaceutics. Mitochondrion, 2004. 3(4): p. 229–44.
Weissig, V., et al., Mitochondria-specific nanotechnology. Nanomed, 2007. 2(3): p. 275–85.
Working, P.K., et al., Reduction of the cardiotoxicity of doxorubicin in rabbits and dogs by encapsulation in long-circulating, pegylated liposomes. J Pharmacol Exp Ther, 1999. 289(2): p. 1128–33.
Xie, W., et al., Nuclear targeted nanoprobe for single living cell detection by surface-enhanced Raman scattering. Bioconjug Chem, 2009. 20(4): p. 768–73.
Xiong, X.B., et al., Multifunctional polymeric micelles for enhanced intracellular delivery of doxorubicin to metastatic cancer cells. Pharm Res, 2008. 25(11): p. 2555–66.
Xu, Z.P., et al., Subcellular compartment targeting of layered double hydroxide nanoparticles. J Control Release, 2008. 130(1): p. 86–94.
Yamada, Y. and H. Harashima, Mitochondrial drug delivery systems for macromolecule and their therapeutic application to mitochondrial diseases. Adv Drug Deliv Rev, 2008. 60(13–14): p. 1439–62.
Yamada, Y., et al., MITO-Porter: A liposome-based carrier system for delivery of macromolecules into mitochondria via membrane fusion. Biochim Biophys Acta, 2008. 1778(2): p. 423–32.
Yang, T., et al., Enhanced solubility and stability of PEGylated liposomal paclitaxel: in vitro and in vivo evaluation. Int J Pharm, 2007. 338(1–2): p. 317–26.
Yessine, M.A. and J.C. Leroux, Membrane-destabilizing polyanions: interaction with lipid bilayers and endosomal escape of biomacromolecules. Adv Drug Deliv Rev, 2004. 56(7): p. 999–1021.
Yuan, X., et al., SiRNA drug delivery by biodegradable polymeric nanoparticles. J Nanosci Nanotechnol, 2006. 6(9–10): p. 2821–8.
Zanta, M.A., P. Belguise-Valladier, and J.P. Behr, Gene delivery: a single nuclear localization signal peptide is sufficient to carry DNA to the cell nucleus. Proc Natl Acad Sci USA, 1999. 96(1): p. 91–6.
Zheng, G., et al., Low-density lipoprotein reconstituted by pyropheophorbide cholesteryl oleate as target-specific photosensitizer. Bioconjug Chem, 2002. 13(3): p. 392–6.
Zheng, G., et al., Rerouting lipoprotein nanoparticles to selected alternate receptors for the targeted delivery of cancer diagnostic and therapeutic agents. Proc Natl Acad Sci USA, 2005. 102(49): p. 17757–62.
Zullo, S.J., Gene therapy of mitochondrial DNA mutations: a brief, biased history of allotopic expression in mammalian cells. Semin Neurol, 2001. 21(3): p. 327–35.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media B.V.
About this chapter
Cite this chapter
Solomon, M., D’Souza, G.G.M. (2011). Approaches to Achieving Sub-cellular Targeting of Bioactives Using Pharmaceutical Nanocarriers. In: Prokop, A. (eds) Intracellular Delivery. Fundamental Biomedical Technologies, vol 5. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-1248-5_2
Download citation
DOI: https://doi.org/10.1007/978-94-007-1248-5_2
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-1247-8
Online ISBN: 978-94-007-1248-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)